Search Within

Victoria M Richon

Formats
  1. Journal Article (49)
  2. Meeting Abstract (37)
  3. Book Section (4)
  4. Conference Paper (1)
Groups
  1. Surgery (11)
  2. Center for Hematologic Malignancies (10)
  3. Department of Medicine (10)
  4. Solid Tumor Oncology Division (8)
  5. Genitourinary Oncology Service (6)
  6. Pediatric Leukemia (6)

More Groups

People
  1. Paul Marks (77)
  2. Richard Rifkind (76)
  3. Xianbo Zhou (11)
  4. Carlos Cordon-Cardo (10)
  5. Hiroaki Kiyokawa (9)
  6. Gisela Venta-Perez (8)

More People

Years
  1. 2004 (2)
  2. 2003 (3)
  3. 2002 (6)
  4. 2001 (11)
  5. 2000 (11)
  6. 1999 (11)

More Years

Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (20)
  2. Proceedings of the National Academy of Sciences of the United States of America (11)
  3. Blood (8)
  4. Cancer Research (7)
  5. Clinical Cancer Research (6)
  6. Anticancer Research (5)

More Publications

Publishers
  1. American Association for Cancer Research (35)
  2. National Academy of Sciences (11)
  3. American Society of Hematology (8)
  4. International Institute of Anticancer Research (5)
  5. Nature Publishing Group (4)
  6. Elsevier Science, Inc. (3)

More Publishers

Results (91)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histone deacetylase inhibitor selectively induces p21WAF1 expressjon and gene-associated histone acetylation
    Journal Article

    Richon, V. M.; Sandhoff, T. W.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the National Academy of Sciences of the United States of America (2000)

    Fulltext@MSK | Save
  • Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5
    Journal Article

    Zhou, X.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the National Academy of Sciences of the United States of America (2000)

    Fulltext@MSK | Save
  • Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
    Journal Article

    Butler, L. M.; Agus, D. B.; Scher, H. I.; Higgins, B.; Rose, A.; Cordon-Cardo, C.; Thaler, H. T.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.
    Cancer Research (2000)

    Fulltext@MSK | Save
  • Induction of apoptosis in human neuroblastoma by a histone deacetylase inhibitor
    Meeting Abstract

    Glick, R. D.; Swendeman, S.; Coffey, D. C.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; La Quaglia, M. P.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save
  • Cloning of the cDNA encoding phenylalanyl tRNA synthetase α-subunit-like protein whose expression is down regulated during differentiation
    Meeting Abstract

    Zhou, X.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save
  • The hydroxamic acid class of hybrid polar cytodifferentiation agents are potent inhibitors of histone deacetylase activity
    Meeting Abstract

    Richon, V. M.; Tolentino, T.; Breslow, R.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save
  • Initial clinical evaluation of 'transcription therapy' for cancer: All-trans retinoic acid plus phenylbutyrate
    Meeting Abstract

    Novick, S.; Camacho, L.; Gallagher, R.; Chanel, S.; Ho, R.; Tolentino, T.; Richon, V.; Pandolfi, P. P.; Warrell, R. P.
    Blood (1999)

    Fulltext@MSK | Save
  • Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-x(L), c-Jun, and p21(CIP1), but independent of p53
    Journal Article

    Vrana, J. A.; Decker, R. H.; Johnson, C. R.; Wang, Z.; Jarvis, W. D.; Richon, V. M.; Ehinger, M.; Fisher, P. B.; Grant, S.
    Oncogene (1999)

    Fulltext@MSK | Save
  • Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
    Journal Article

    Finnin, M. S.; Donigian, J. R.; Cohen, A.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.; Breslow, R.; Pavletich, N. P.
    Nature (1999)

    Fulltext@MSK | Save
  • Prognostic significance of transcription factor E2F-1 in bladder cancer: Genotypic and phenotypic characterization
    Journal Article

    Rabbani, F.; Richon, V. M.; Orlow, I.; Lu, M. L.; Drobnjak, M.; Dudas, M.; Charytonowicz, E.; Dalbagni, G.; Cordon-Cardo, C.
    JNCI: Journal of the National Cancer Institute (1999)

    Fulltext@MSK | Save